Triflupromazine

Triflupromazine
Clinical data
AHFS/Drugs.com Micromedex Detailed Consumer Information
MedlinePlus a600010
ATC code N05AA05 (WHO)
Legal status
Legal status
Identifiers
CAS Number 146-54-3 YesY
PubChem (CID) 5568
IUPHAR/BPS 4330
DrugBank DB00508 N
ChemSpider 5367 N
UNII RO16TQF95Y N
KEGG D00390 N
ChEBI CHEBI:9711 N
ChEMBL CHEMBL570 N
ECHA InfoCard 100.005.158
Chemical and physical data
Formula C18H19F3N2S
Molar mass 352.418 g/mol
3D model (Jmol) Interactive image
 NYesY (what is this?)  (verify)

Triflupromazine (Vesprin) is an antipsychotic medication of the phenothiazine class. Among different effects of triflupromazine indication for use of this drug is severe emesis. Due to its potential side effects (triflupromazine has higher risk for side effects than many other antipsychotics) it is not gold standard in antiemetic therapy.

Serious side effects of triflupromazine can be akathisia and tardive dyskinesia as well as the rare, but potentially fatal, neuroleptic malignant syndrome.

This article is issued from Wikipedia - version of the 3/28/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.